human | Q5 |
P496 | ORCID iD | 0000-0002-0097-9971 |
P2038 | ResearchGate profile ID | Chris_Haiman |
P214 | VIAF ID | 948150323752009970436 |
P7859 | WorldCat Identities ID (superseded) | lccn-n2017186642 |
P734 | family name | Haiman | Q36979220 |
Haiman | Q36979220 | ||
Haiman | Q36979220 | ||
P735 | given name | Christopher | Q1084472 |
Christopher | Q1084472 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q90339863 | 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population |
Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
Q35064747 | 8q24 risk alleles and prostate cancer in African-Barbadian men. |
Q60460674 | A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk |
Q94683498 | A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry |
Q55210146 | A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. |
Q35327105 | A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer |
Q40071308 | A Loss-Of-Function Splice Acceptor Variant in IGF2 is Protective for Type 2 Diabetes |
Q40597341 | A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci |
Q36927005 | A case-control analysis of smoking and breast cancer in African American women: findings from the AMBER Consortium |
Q46378338 | A common 8q24 variant in prostate and breast cancer from a large nested case-control study |
Q36667989 | A common genetic risk factor for colorectal and prostate cancer |
Q34585661 | A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations |
Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
Q33980349 | A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians |
Q33308309 | A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort |
Q45305326 | A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. |
Q35605845 | A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). |
Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
Q34211808 | A comprehensive examination of breast cancer risk loci in African American women |
Q44307819 | A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort |
Q33731355 | A functionally significant SNP in TP53 and breast cancer risk in African-American women |
Q35093501 | A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer |
Q37109758 | A genome-wide association study of breast cancer in women of African ancestry |
Q37705188 | A genome-wide association study of prostate cancer in West African men |
Q35177444 | A genome-wide pleiotropy scan for prostate cancer risk |
Q34628377 | A genomewide admixture map for Latino populations |
Q33306108 | A high-density admixture scan in 1,670 African Americans with hypertension |
Q35925225 | A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences |
Q34113217 | A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q30416161 | A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry |
Q35248192 | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer |
Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
Q36477652 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease |
Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
Q43612263 | A polymorphism in CYP17 and endometrial cancer risk |
Q43528266 | A priori-defined diet quality indices, biomarkers and risk for type 2 diabetes in five ethnic groups: the Multiethnic Cohort |
Q46083367 | A promoter polymorphism in the CASP8 gene is not associated with cancer risk |
Q37981608 | A review of cancer in U.S. Hispanic populations |
Q51541955 | A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. |
Q55470614 | A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. |
Q35870195 | A systematic approach to understand the functional consequences of non-protein coding risk regions |
Q46226734 | A systematic assessment of common genetic variation in CYP11A and risk of breast cancer |
Q57750722 | A tetranucleotide repeat polymorphism inCYP19 and breast cancer risk |
Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
Q43985011 | A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans |
Q62583660 | AA9int: SNP interaction pattern search using non-hierarchical additive model set |
Q36083454 | ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3). |
Q57785674 | Abstract LB-282: Transethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A |
Q61948762 | Abstract LB-448: Genome-wide association study identifies new prostate cancer susceptibility loci |
Q34472668 | Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium |
Q37271961 | Admixture Mapping of African-American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes |
Q35080445 | Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. |
Q35856257 | Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas |
Q33450573 | Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. |
Q34206098 | African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts |
Q28386602 | Age-related clonal hematopoiesis associated with adverse outcomes |
Q64989893 | Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. |
Q37417691 | Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study |
Q37437960 | An admixture scan in 1,484 African American women with breast cancer |
Q39706039 | An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium |
Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
Q36865904 | Analysis of Latino populations from GALA and MEC studies reveals genomic loci with biased local ancestry estimation |
Q36055011 | Analysis of case-control association studies with known risk variants |
Q24170413 | Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types |
Q37118791 | Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels |
Q97070156 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q36123803 | Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses |
Q37205569 | Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort |
Q38686091 | Association of Coffee Consumption With Total and Cause-Specific Mortality Among Nonwhite Populations |
Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
Q35764730 | Association of Genes, Pathways, and Haplogroups of the Mitochondrial Genome with the Risk of Colorectal Cancer: The Multiethnic Cohort |
Q35588251 | Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population |
Q36191018 | Association of breast cancer risk loci with breast cancer survival |
Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
Q34457646 | Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study |
Q37306082 | Association of diabetes with prostate cancer risk in the multiethnic cohort |
Q43636885 | Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. |
Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
Q37127877 | Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic populations: the PAGE study |
Q34314362 | Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium |
Q36722084 | Associations Between Genetic Ancestries and Nicotine Metabolism Biomarkers in the Multiethnic Cohort Study |
Q91045562 | Associations of autozygosity with a broad range of human phenotypes |
Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q36792641 | Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation |
Q35652541 | Atopic allergic conditions and colorectal cancer risk in the Multiethnic Cohort Study |
Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
Q60907509 | Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
Q60917567 | Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions |
Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
Q35951033 | Benzene Uptake and Glutathione S-transferase T1 Status as Determinants of S-Phenylmercapturic Acid in Cigarette Smokers in the Multiethnic Cohort |
Q37045556 | Blood lipids and prostate cancer: a Mendelian randomization analysis |
Q35852637 | Body Mass Index Genetic Risk Score and Endometrial Cancer Risk |
Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
Q39734134 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States |
Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
Q36558326 | CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants |
Q44449983 | CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). |
Q33616702 | CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium |
Q34515023 | Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations |
Q24169697 | Characterization of large structural genetic mosaicism in human autosome |
Q37163691 | Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583 |
Q39002074 | Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry |
Q33842251 | Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. |
Q33921139 | Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans |
Q46083526 | Characterizing the neighborhood obesogenic environment in the Multiethnic Cohort: a multi-level infrastructure for cancer health disparities research |
Q30815307 | Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study |
Q47267193 | Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3). |
Q56089366 | Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts |
Q56089362 | Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3) |
Q91647649 | Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3) |
Q47242967 | Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men. |
Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
Q36600605 | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk |
Q36856357 | Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls |
Q35868793 | Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) |
Q45135637 | Common genetic variation at PTEN and risk of sporadic breast and prostate cancer |
Q35749326 | Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study |
Q46140030 | Common genetic variation in the sex steroid hormone-binding globulin (SHBG) gene and circulating shbg levels among postmenopausal women: the Multiethnic Cohort |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q39389957 | Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese |
Q57251792 | Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer |
Q34631785 | Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer |
Q24614574 | Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium |
Q34622559 | Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). |
Q45960056 | Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations. |
Q37533894 | Comprehensive functional annotation of 77 prostate cancer risk loci |
Q34744860 | Comprehensive functional annotation of seventy-one breast cancer risk Loci |
Q33701819 | Consistent association of type 2 diabetes risk variants found in europeans in diverse racial and ethnic groups |
Q28384670 | Consistent directions of effect for established type 2 diabetes risk variants across populations: the population architecture using Genomics and Epidemiology (PAGE) Consortium |
Q46112906 | Correction to: Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium |
Q45912452 | Correction: African Ancestry and Its Correlation to Type 2 Diabetes in African Americans: A Genetic Admixture Analysis in Three U.S. Population Cohorts. |
Q42348998 | Correction: Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults |
Q28396029 | Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer |
Q45070922 | Cross-Cancer Analysis Reveals Novel Pleiotropic Associations-Response |
Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
Q34096825 | Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia |
Q33768593 | Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer |
Q34478869 | Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation |
Q37396372 | Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities |
Q34441746 | Defining the role of common variation in the genomic and biological architecture of adult human height |
Q23916196 | Detectable clonal mosaicism and its relationship to aging and cancer |
Q28385149 | Detectable clonal mosaicism from birth to old age and its relationship to cancer |
Q51716837 | Diabetes and urothelial cancer risk: the Multiethnic Cohort study. |
Q38719262 | Dietary Red and Processed Meat Intake and Markers of Adiposity and Inflammation: The Multiethnic Cohort Study |
Q30252516 | Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium. |
Q34545744 | Effects of smoking on the genetic risk of obesity: the population architecture using genomics and epidemiology study |
Q34338886 | Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer |
Q30432415 | Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium |
Q35741878 | Established risk factors account for most of the racial differences in cardiovascular disease mortality |
Q46138958 | Ethnic and racial differences in the smoking-related risk of lung cancer |
Q36643784 | Ethnic differences in ovulatory function in nulliparous women |
Q36388749 | Evaluating genetic risk for prostate cancer among Japanese and Latinos |
Q54989897 | Evaluation of 71 Coronary Artery Disease Risk Variants in a Multiethnic Cohort. |
Q31060192 | Evaluation of the metabochip genotyping array in African Americans and implications for fine mapping of GWAS-identified loci: the PAGE study |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
Q60297002 | Exome chip meta-analysis fine maps causal variants and elucidates the genetic architecture of rare coding variants in smoking and alcohol use |
Q64108431 | Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls |
Q33584276 | Exome-wide association study of endometrial cancer in a multiethnic population |
Q40527295 | Exploring Differences in the Aspirin-Colorectal Cancer Association by Sex and Race/Ethnicity: The Multiethnic Cohort Study |
Q34430369 | Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types |
Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
Q37323340 | FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation |
Q27908479 | Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome |
Q37217089 | Fine Mapping and Identification of BMI Loci in African Americans |
Q30275202 | Fine mapping of QT interval regions in global populations refines previously identified QT interval loci and identifies signals unique to African and Hispanic descent populations |
Q35056055 | Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer |
Q33947843 | Fine mapping of the association with obesity at the FTO locus in African-derived populations |
Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
Q33878276 | Fine scale mapping of the breast cancer 16q12 locus |
Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
Q30371049 | Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study. |
Q34388513 | Fine-mapping and initial characterization of QT interval loci in African Americans |
Q36856343 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression |
Q55380382 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q35389444 | Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans |
Q37332218 | Fine-mapping of genome-wide association study-identified risk loci for colorectal cancer in African Americans |
Q30252583 | Fine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci |
Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
Q35097143 | Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer |
Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q38408978 | GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer |
Q35952814 | Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array |
Q50041886 | Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. |
Q36961082 | Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium |
Q34848573 | Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations |
Q34050485 | Generalizability of associations from prostate cancer genome-wide association studies in multiple populations |
Q34716723 | Generalizability of established prostate cancer risk variants in men of African ancestry |
Q34998144 | Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study |
Q37629802 | Generalization and fine mapping of European ancestry-based central adiposity variants in African ancestry populations |
Q57316036 | Genetic Diversity Turns a New PAGE in Our Understanding of Complex Traits |
Q30301097 | Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium |
Q115209620 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus |
Q37436758 | Genetic ancestry and risk of mortality among U.S. Latinas with breast cancer |
Q34960835 | Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts |
Q63457086 | Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex |
Q45962404 | Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population. |
Q33954461 | Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study |
Q24807377 | Genetic determinants of mammographic density |
Q35999323 | Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study |
Q59544908 | Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners |
Q33488319 | Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). |
Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q28390241 | Genetic risk factors for BMI and obesity in an ethnically diverse population: results from the population architecture using genomics and epidemiology (PAGE) study |
Q48197879 | Genetic risk of prostate cancer in ugandan men. |
Q35806601 | Genetic risk variants associated with in situ breast cancer |
Q22305005 | Genetic studies of body mass index yield new insights for obesity biology |
Q62583135 | Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma |
Q28392218 | Genetic variants associated with fasting glucose and insulin concentrations in an ethnically diverse population: results from the Population Architecture using Genomics and Epidemiology (PAGE) study |
Q50020878 | Genetic variants in immune-related pathways and breast cancer risk in African American women in the AMBER consortium. |
Q39373193 | Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry |
Q37220236 | Genetic variants in the mTOR pathway and breast cancer risk in African American women |
Q34592585 | Genetic variation and reproductive timing: African American women from the Population Architecture using Genomics and Epidemiology (PAGE) Study |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q46750307 | Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women |
Q37219153 | Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk |
Q46552527 | Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q24811147 | Genetic variation in the HSD17B1 gene and risk of prostate cancer |
Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
Q37482022 | Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium |
Q34042346 | Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach |
Q36741744 | Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium |
Q40638709 | Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium |
Q37381735 | Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium |
Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
Q96683580 | Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer |
Q30417624 | Genome-wide association of body fat distribution in African ancestry populations suggests new loci |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q40346126 | Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer |
Q38668307 | Genome-wide association studies of cancer in diverse populations |
Q28383750 | Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population |
Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
Q35565707 | Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium |
Q28659283 | Genome-wide association study identifies multiple loci associated with bladder cancer risk |
Q34314018 | Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer |
Q28924380 | Genome-wide association study identifies new prostate cancer susceptibility loci |
Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
Q28924377 | Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer |
Q37045108 | Genome-wide association study of age at menarche in African-American women |
Q34375940 | Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. |
Q36927009 | Genome-wide association study of colorectal cancer in Hispanics |
Q28943291 | Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project |
Q28660394 | Genome-wide association study of endometrial cancer in E2C2 |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q35009643 | Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. |
Q38970751 | Genome-wide association study of prostate cancer-specific survival |
Q28943359 | Genome-wide interaction study of smoking and bladder cancer risk |
Q47248078 | Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci |
Q36001590 | Genome-wide meta-analyses of smoking behaviors in African Americans |
Q49816011 | Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. |
Q30352681 | Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits. |
Q33610252 | Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults |
Q28655044 | Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture |
Q34650062 | Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population |
Q46573151 | Germ line variation at 8q24 and endometrial cancer risk |
Q58611475 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
Q36640906 | Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent |
Q31047674 | HNF1B and endometrial cancer risk: results from the PAGE study |
Q46952791 | Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies |
Q43985413 | Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort |
Q37484235 | Haplotypes of the estrogen receptor beta gene and breast cancer risk |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
Q33739254 | High mortality due to sepsis in Native Hawaiians and African Americans: The Multiethnic Cohort |
Q64234371 | High-Quality Diets Are Associated With Reduced Risk of Hepatocellular Carcinoma and Chronic Liver Disease: The Multiethnic Cohort |
Q38827821 | High-Quality Diets Associate With Reduced Risk of Colorectal Cancer: Analyses of Diet Quality Indexes in the Multiethnic Cohort |
Q37371491 | Hormone-related pathways and risk of breast cancer subtypes in African American women |
Q33348545 | IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). |
Q34078803 | IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort |
Q33883948 | IGF2R missense single-nucleotide polymorphisms and breast cancer risk: the multiethnic cohort study |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
Q29417155 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array |
Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
Q36069872 | Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer |
Q28474694 | Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium |
Q36198138 | Identification of a new prostate cancer susceptibility locus on chromosome 8q24. |
Q36754771 | Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry |
Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
Q61448654 | Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q29417022 | Identification of seven new prostate cancer susceptibility loci through a genome-wide association study |
Q36331604 | Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q31036626 | Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry |
Q35747559 | Improved imputation of common and uncommon SNPs with a new reference set. |
Q23924183 | Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 |
Q30662194 | Imputation of coding variants in African Americans: better performance using data from the exome sequencing project |
Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
Q36384402 | Informed conditioning on clinical covariates increases power in case-control association studies |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q55693698 | Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival. |
Q36849912 | Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). |
Q33845203 | Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival |
Q36065460 | Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions |
Q35873064 | Interaction between Red Meat Intake and NAT2 Genotype in Increasing the Risk of Colorectal Cancer in Japanese and African Americans |
Q40071035 | Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium |
Q35166701 | Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium |
Q40515571 | Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis |
Q34698777 | Investigation of gene-by-sex interactions for lipid traits in diverse populations from the population architecture using genomics and epidemiology study |
Q63352570 | Is high vitamin B12 status a cause of lung cancer? |
Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
Q38730359 | Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes |
Q36250030 | Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer |
Q35119669 | Large-scale fine mapping of the HNF1B locus and prostate cancer risk |
Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q57030056 | Large-scale transcriptome-wide association study identifies new prostate cancer risk regions |
Q36590875 | Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations |
Q34572467 | Leveraging population admixture to characterize the heritability of complex traits |
Q50050403 | Low diet quality and the risk of stroke mortality: the multiethnic cohort study. |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q45187084 | MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study |
Q30276785 | Mapping adipose and muscle tissue expression quantitative trait loci in African Americans to identify genes for type 2 diabetes and obesity |
Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
Q98772941 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
Q35656389 | Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer |
Q37143043 | Meta-Analysis of Rare Variant Association Tests in Multiethnic Populations |
Q35785297 | Meta-analysis identifies common variants associated with body mass index in east Asians |
Q33649334 | Meta-analysis of loci associated with age at natural menopause in African-American women |
Q63352621 | Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci |
Q36044839 | Metabolites of the Polycyclic Aromatic Hydrocarbon Phenanthrene in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer |
Q30977635 | Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q35576887 | Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women |
Q115238429 | Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study |
Q33925293 | Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study |
Q92912555 | Multiple functional variants in the IL1RL1 region are pretransplant markers for risk of GVHD and infection deaths |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q35646703 | Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans |
Q42038345 | Multiple regions within 8q24 independently affect risk for prostate cancer |
Q35114362 | New genetic loci link adipose and insulin biology to body fat distribution |
Q36963560 | No Association between the Mitochondrial Genome and Prostate Cancer Risk: The Multiethnic Cohort |
Q34359901 | No association of risk variants for diabetes and obesity with breast cancer: the Multiethnic Cohort and PAGE studies |
Q35220510 | No association of type 2 diabetes risk variants and prostate cancer risk: the multiethnic cohort and PAGE |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q37491987 | No evidence of interaction between known lipid-associated genetic variants and smoking in the multi-ethnic PAGE population |
Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
Q56359054 | Novel Common Genetic Susceptibility Loci for Colorectal Cancer |
Q40291645 | Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans |
Q35634515 | Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium |
Q37654985 | One thousand genomes imputation in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium aggressive prostate cancer genome-wide association study |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q33705238 | PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). |
Q34736954 | Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium |
Q34574903 | Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network |
Q116031795 | Plant-based dietary patterns defined by a priori indices and colorectal cancer risk by sex and race/ethnicity: the Multiethnic Cohort Study |
Q36831883 | Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
Q28383788 | Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia |
Q37570238 | Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia |
Q35112029 | Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q24791382 | Polymorphic repeat in AIB1 does not alter breast cancer risk |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q24810286 | Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study |
Q44325849 | Polymorphisms in steroid hormone pathway genes and mammographic density |
Q39524941 | Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium |
Q33733210 | Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer |
Q34473598 | Population genetic structure and origins of Native Hawaiians in the multiethnic cohort study |
Q34155371 | Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women |
Q37228261 | Post-genome-wide association study challenges for lipid traits: describing age as a modifier of gene-lipid associations in the Population Architecture using Genomics and Epidemiology (PAGE) study |
Q36871025 | Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women |
Q56516219 | Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium |
Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q37223335 | Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status |
Q41584352 | Prediction of individual genetic risk to prostate cancer using a polygenic score |
Q37103045 | Prostate Cancer Susceptibility in Men of African Ancestry at 8q24 |
Q36765569 | Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
Q38668303 | Quantifying the Genetic Correlation between Multiple Cancer Types |
Q24656179 | Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3) |
Q36009422 | RAD51B in Familial Breast Cancer |
Q108819063 | Race, ethnicity, community-level socioeconomic factors, and risk of COVID-19 in the United States and the United Kingdom |
Q36054387 | Racial/ethnic differences in lifestyle-related factors and prostate cancer risk: the Multiethnic Cohort Study |
Q46410535 | Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study |
Q33539723 | Rapid assessment of genetic ancestry in populations of unknown origin by genome-wide genotyping of pooled samples |
Q57177774 | Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease |
Q38697838 | Reducing GWAS Complexity |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q33835331 | Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. |
Q34870700 | Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry |
Q38623211 | Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant |
Q40498649 | Replication of associations between genetic polymorphisms and chronic graft-versus-host disease |
Q35661241 | Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). |
Q28383099 | Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study |
Q34447165 | Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese |
Q35815958 | Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci |
Q38382935 | SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns |
Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
Q24656096 | Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort |
Q34669917 | Self-reported ethnicity, genetic structure and the impact of population stratification in a multiethnic study |
Q57271433 | Sequence Variants of Estrogen Receptor and Risk of Prostate Cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
Q24317364 | Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico |
Q29417074 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study |
Q46745482 | Sex and ethnic/racial-specific risk factors for gallbladder disease |
Q61118451 | Shared heritability and functional enrichment across six solid cancers |
Q64004349 | Shared heritability and functional enrichment across six solid cancers |
Q47645244 | Sleep duration and incidence of type 2 diabetes: the Multiethnic Cohort |
Q55667339 | Stepwise approach to SNP-set analysis illustrated with the Metabochip and colorectal cancer in Japanese Americans of the Multiethnic Cohort. |
Q36223643 | Strategies for Enriching Variant Coverage in Candidate Disease Loci on a Multiethnic Genotyping Array |
Q36110159 | Susceptibility variants for obesity and colorectal cancer risk: the multiethnic cohort and PAGE studies |
Q46136876 | T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study |
Q28397509 | Telomere structure and maintenance gene variants and risk of five cancer types |
Q55384494 | Testing the Predictive Validity of the Healthy Eating Index-2015 in the Multiethnic Cohort: Is the Score Associated with a Reduced Risk of All-Cause and Cause-Specific Mortality? |
Q34372389 | The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease |
Q37390854 | The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer |
Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
Q94552258 | The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action |
Q40343659 | The Dietary Inflammatory Index Is Associated with Colorectal Cancer Risk in the Multiethnic Cohort |
Q60923095 | The Dietary Inflammatory Index and All-Cause, Cardiovascular Disease, and Cancer Mortality in the Multiethnic Cohort Study |
Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
Q28752426 | The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions |
Q35223497 | The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study |
Q37578078 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
Q77678688 | The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study |
Q34000325 | The association of diabetes with colorectal cancer risk: the Multiethnic Cohort |
Q63865847 | The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies |
Q37151220 | The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study |
Q34963910 | The contribution of common genetic variation to nicotine and cotinine glucuronidation in multiple ethnic/racial populations |
Q38856899 | The contribution of rare variation to prostate cancer heritability |
Q36133295 | The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium |
Q36326943 | The efficacy of detecting variants with small effects on the Affymetrix 6.0 platform using pooled DNA. |
Q57174781 | The genetic underpinnings of variation in ages at menarche and natural menopause among women from the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) Study: A trans-ethnic meta-analysis |
Q36796006 | The influence of obesity-related single nucleotide polymorphisms on BMI across the life course: the PAGE study |
Q30428393 | The landscape of recombination in African Americans |
Q33686851 | The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data |
Q74592748 | The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer |
Q74147573 | The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer |
Q46012348 | The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort. |
Q46477592 | The role of established breast cancer susceptibility loci in mammographic density in young women |
Q35049307 | The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery |
Q29248193 | Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 |
Q58722486 | Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers |
Q48142652 | Trans-ethnic analysis of metabochip data identifies two new loci associated with BMI. |
Q38845982 | Trans-ethnic fine-mapping of genetic loci for body mass index in the diverse ancestral populations of the Population Architecture using Genomics and Epidemiology (PAGE) Study reveals evidence for multiple signals at established loci |
Q34649888 | Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained |
Q37686157 | Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach |
Q34270911 | Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. |
Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
Q40041955 | Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium |
Q79290429 | Transferability of tag SNPs in genetic association studies in multiple populations |
Q37157438 | Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium |
Q35575585 | Two susceptibility loci identified for prostate cancer aggressiveness |
Q92994868 | Two truncating variants in FANCC and breast cancer risk |
Q50020860 | Type 2 Diabetes and Colorectal Cancer Survival: The Multiethnic Cohort. |
Q35096343 | Type 2 diabetes risk variants and colorectal cancer risk: the Multiethnic Cohort and PAGE studies |
Q39021101 | Type II Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort |
Q33404621 | Use of weighted reference panels based on empirical estimates of ancestry for capturing untyped variation |
Q35032730 | Validation of genome-wide prostate cancer associations in men of African descent |
Q33515702 | Variation in genetic admixture and population structure among Latinos: the Los Angeles Latino eye study (LALES). |
Q40012482 | Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
Q35164176 | Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3). |
Q40050925 | Weight change in older adults and mortality: the Multiethnic Cohort Study |
Q36895709 | Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk |
Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.